Titre : Loi de Poisson

Loi de Poisson : Questions médicales fréquentes

Termes MeSH sélectionnés :

Developing Countries
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Loi de Poisson : Questions médicales les plus fréquentes", "headline": "Loi de Poisson : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Loi de Poisson : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-05", "dateModified": "2025-03-31", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Loi de Poisson" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lois statistiques", "url": "https://questionsmedicales.fr/mesh/D016008", "about": { "@type": "MedicalCondition", "name": "Lois statistiques", "code": { "@type": "MedicalCode", "code": "D016008", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N06.850.520.830.994" } } }, "about": { "@type": "MedicalCondition", "name": "Loi de Poisson", "alternateName": "Poisson Distribution", "code": { "@type": "MedicalCode", "code": "D016012", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Cécile Kremer", "url": "https://questionsmedicales.fr/author/C%C3%A9cile%20Kremer", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Andrea Torneri", "url": "https://questionsmedicales.fr/author/Andrea%20Torneri", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Sien Boesmans", "url": "https://questionsmedicales.fr/author/Sien%20Boesmans", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Hanne Meuwissen", "url": "https://questionsmedicales.fr/author/Hanne%20Meuwissen", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Selina Verdonschot", "url": "https://questionsmedicales.fr/author/Selina%20Verdonschot", "affiliation": { "@type": "Organization", "name": "" } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators.", "datePublished": "2022-06-03", "url": "https://questionsmedicales.fr/article/35657484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s43441-022-00415-y" } }, { "@type": "ScholarlyArticle", "name": "Cost-benefit analysis of a multicomponent breastfeeding promotion and support intervention in a developing country.", "datePublished": "2024-07-19", "url": "https://questionsmedicales.fr/article/39028742", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0295194" } }, { "@type": "ScholarlyArticle", "name": "Validating the Delone and Mclean's model in a developing country's infectious disease pandemic context.", "datePublished": "2024-06-17", "url": "https://questionsmedicales.fr/article/38886674", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12879-024-09483-x" } }, { "@type": "ScholarlyArticle", "name": "Economic uncertainty and population health: insights from emerging markets and developing countries.", "datePublished": "2023-10-25", "url": "https://questionsmedicales.fr/article/37954045", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2023.1292236" } }, { "@type": "ScholarlyArticle", "name": "Burning issues: Unraveling the nexus between dysfunctional institutions and counterfeiting in developing countries.", "datePublished": "2023-10-06", "url": "https://questionsmedicales.fr/article/37852037", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.socscimed.2023.116292" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Environnement et santé publique", "item": "https://questionsmedicales.fr/mesh/D004778" }, { "@type": "ListItem", "position": 3, "name": "Santé publique", "item": "https://questionsmedicales.fr/mesh/D011634" }, { "@type": "ListItem", "position": 4, "name": "Méthodes épidémiologiques", "item": "https://questionsmedicales.fr/mesh/D004812" }, { "@type": "ListItem", "position": 5, "name": "Statistiques comme sujet", "item": "https://questionsmedicales.fr/mesh/D013223" }, { "@type": "ListItem", "position": 6, "name": "Lois statistiques", "item": "https://questionsmedicales.fr/mesh/D016008" }, { "@type": "ListItem", "position": 7, "name": "Loi de Poisson", "item": "https://questionsmedicales.fr/mesh/D016012" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Loi de Poisson - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Loi de Poisson", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-18", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Loi de Poisson", "description": "Comment identifier une distribution de Poisson ?\nQuels outils statistiques sont utilisés ?\nQuand utiliser la loi de Poisson ?\nQuels sont les critères d'application ?\nComment vérifier l'adéquation du modèle ?", "url": "https://questionsmedicales.fr/mesh/D016012?mesh_terms=Developing+Countries&page=7#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Loi de Poisson", "description": "Quels symptômes modélise-t-on avec la loi de Poisson ?\nLa loi de Poisson peut-elle prédire des épidémies ?\nQuels événements sont souvent analysés ?\nPeut-on modéliser des décès avec cette loi ?\nQuels types de maladies sont concernés ?", "url": "https://questionsmedicales.fr/mesh/D016012?mesh_terms=Developing+Countries&page=7#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Loi de Poisson", "description": "Comment la loi de Poisson aide-t-elle à la prévention ?\nPeut-on prédire des épidémies avec cette loi ?\nQuels événements préventifs sont modélisés ?\nComment évaluer l'impact des campagnes ?\nQuels facteurs influencent la prévention ?", "url": "https://questionsmedicales.fr/mesh/D016012?mesh_terms=Developing+Countries&page=7#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Loi de Poisson", "description": "Comment la loi de Poisson aide-t-elle en traitement ?\nPeut-on ajuster les traitements avec cette loi ?\nComment évaluer les effets secondaires ?\nLa loi de Poisson influence-t-elle la recherche ?\nQuels traitements sont souvent analysés ?", "url": "https://questionsmedicales.fr/mesh/D016012?mesh_terms=Developing+Countries&page=7#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Loi de Poisson", "description": "Quelles complications peuvent être modélisées ?\nComment la loi de Poisson aide-t-elle à comprendre les complications ?\nPeut-on prédire des complications avec cette loi ?\nQuels types de complications sont souvent étudiés ?\nComment réduire les complications ?", "url": "https://questionsmedicales.fr/mesh/D016012?mesh_terms=Developing+Countries&page=7#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Loi de Poisson", "description": "Quels facteurs influencent la loi de Poisson ?\nComment identifier les facteurs de risque ?\nLes comportements influencent-ils les résultats ?\nQuels facteurs environnementaux sont considérés ?\nComment les facteurs de risque sont-ils utilisés ?", "url": "https://questionsmedicales.fr/mesh/D016012?mesh_terms=Developing+Countries&page=7#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment identifier une distribution de Poisson ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "On vérifie si les événements sont rares et indépendants, et on utilise des tests statistiques." } }, { "@type": "Question", "name": "Quels outils statistiques sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de chi carré et les tests de Poisson sont couramment utilisés pour l'analyse." } }, { "@type": "Question", "name": "Quand utiliser la loi de Poisson ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Elle est utilisée pour modéliser des événements rares comme les accidents ou les maladies." } }, { "@type": "Question", "name": "Quels sont les critères d'application ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les événements doivent être indépendants et se produire à un taux constant dans le temps." } }, { "@type": "Question", "name": "Comment vérifier l'adéquation du modèle ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "On compare les données observées avec les données attendues par le modèle de Poisson." } }, { "@type": "Question", "name": "Quels symptômes modélise-t-on avec la loi de Poisson ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "On modélise des événements comme des cas de maladies ou des accidents dans un intervalle donné." } }, { "@type": "Question", "name": "La loi de Poisson peut-elle prédire des épidémies ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut estimer le nombre de cas d'une maladie dans un temps donné, comme une épidémie." } }, { "@type": "Question", "name": "Quels événements sont souvent analysés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les événements comme les admissions à l'hôpital ou les infections nosocomiales sont analysés." } }, { "@type": "Question", "name": "Peut-on modéliser des décès avec cette loi ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la loi de Poisson est utilisée pour modéliser le nombre de décès dans une population sur une période." } }, { "@type": "Question", "name": "Quels types de maladies sont concernés ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des maladies infectieuses, des accidents et des maladies chroniques peuvent être modélisées." } }, { "@type": "Question", "name": "Comment la loi de Poisson aide-t-elle à la prévention ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'estimer le risque d'événements indésirables et d'orienter les stratégies de prévention." } }, { "@type": "Question", "name": "Peut-on prédire des épidémies avec cette loi ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à prédire le nombre de cas d'épidémies et à planifier des interventions préventives." } }, { "@type": "Question", "name": "Quels événements préventifs sont modélisés ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "On modélise des événements comme les vaccinations et les campagnes de sensibilisation." } }, { "@type": "Question", "name": "Comment évaluer l'impact des campagnes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "On utilise la loi de Poisson pour analyser le nombre de cas avant et après les campagnes de prévention." } }, { "@type": "Question", "name": "Quels facteurs influencent la prévention ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs comme le taux de vaccination et l'accès aux soins influencent les résultats préventifs." } }, { "@type": "Question", "name": "Comment la loi de Poisson aide-t-elle en traitement ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'évaluer l'efficacité des traitements en analysant le nombre d'événements indésirables." } }, { "@type": "Question", "name": "Peut-on ajuster les traitements avec cette loi ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les données de Poisson aident à ajuster les traitements en fonction des résultats observés." } }, { "@type": "Question", "name": "Comment évaluer les effets secondaires ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "On utilise la loi de Poisson pour modéliser le nombre d'effets secondaires dans des essais cliniques." } }, { "@type": "Question", "name": "La loi de Poisson influence-t-elle la recherche ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle guide la recherche sur l'impact des traitements en analysant les événements rares." } }, { "@type": "Question", "name": "Quels traitements sont souvent analysés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements pour les maladies infectieuses et les interventions chirurgicales sont souvent analysés." } }, { "@type": "Question", "name": "Quelles complications peuvent être modélisées ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "On peut modéliser des complications comme les infections post-opératoires ou les effets secondaires." } }, { "@type": "Question", "name": "Comment la loi de Poisson aide-t-elle à comprendre les complications ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle permet d'analyser la fréquence des complications et d'identifier des facteurs de risque." } }, { "@type": "Question", "name": "Peut-on prédire des complications avec cette loi ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle aide à prédire le nombre de complications dans des populations spécifiques après un traitement." } }, { "@type": "Question", "name": "Quels types de complications sont souvent étudiés ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications chirurgicales et les effets indésirables des médicaments sont souvent étudiés." } }, { "@type": "Question", "name": "Comment réduire les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "On utilise les données de Poisson pour identifier les risques et améliorer les protocoles de soins." } }, { "@type": "Question", "name": "Quels facteurs influencent la loi de Poisson ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs comme l'âge, le sexe et les antécédents médicaux influencent les événements modélisés." } }, { "@type": "Question", "name": "Comment identifier les facteurs de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "On analyse les données épidémiologiques pour identifier les facteurs associés à des événements rares." } }, { "@type": "Question", "name": "Les comportements influencent-ils les résultats ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des comportements comme le tabagisme ou l'alimentation peuvent augmenter les risques d'événements." } }, { "@type": "Question", "name": "Quels facteurs environnementaux sont considérés ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme la pollution et l'accès aux soins de santé sont pris en compte dans l'analyse." } }, { "@type": "Question", "name": "Comment les facteurs de risque sont-ils utilisés ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Ils sont utilisés pour orienter les politiques de santé publique et les stratégies de prévention." } } ] } ] }

Sources (10000 au total)

A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators.

In the context of the growth of pharmacovigilance (PV) among developing countries, this systematic review aims to synthesise current research evaluating developing countries' PV systems' performance.... EMBASE, MEDLINE, CINAHL Plus and Web of Science were searched for peer-reviewed studies published in English between 2012 and 2021. Reference lists of included studies were screened. Included studies ... Twenty-one unique studies from 51 countries were included. Of a total possible quality score of 36, most studies were rated medium (n = 7 studies) or high (n = 14 studies). Studies obtained an average... This first systematic review of studies evaluating PV performance in developing countries provides an in-depth understanding of factors affecting PV system performance....

Cost-benefit analysis of a multicomponent breastfeeding promotion and support intervention in a developing country.

Studies on breastfeeding promotion and support interventions suggest some economic benefits. This study assessed the direct and indirect costs of a multicomponent breastfeeding promotion and support i... This is a cost-benefit analysis of data generated from a randomized controlled trial that investigated whether provision of a multicomponent breastfeeding promotion and support intervention to Lebanes... The prevalence of Exclusive/Predominant breastfeeding among participants declined from 51.6% in the first month to 6.6% at the end of second year. The multicomponent breastfeeding intervention incurre... Breastfeeding is associated with significant economic and infant health benefits in the first two years. In the context of the current economic crisis in Lebanon, this study provides further evidence ...

Validating the Delone and Mclean's model in a developing country's infectious disease pandemic context.

This study aimed at validating the updated DeLone and McLean's information systems success model (D&MISS) in a developing country's infectious disease pandemic preparedness and response context. The f... A cross-sectional study design that involved a multi-stage probability sampling approach to select eligible healthcare workers was applied. Conducted in Nigeria and Liberia, 576 primary healthcare wor... 70% of the observed variance in the Net Benefit construct was explained by the predictive influence of the Use and User Satisfaction constructs. The Use construct had a slightly more substantial predi... The D&MISS model demonstrated its relevance in providing evidence on the gaps of the HISs regarding future pandemic preparedness and response. However, from a future research opportunity, its enhancem...

The impact of laparoscopic gynecological surgery training on the technicity index of a developing country center.

To compare laparoscopic gynecological surgery training between a developed country's reference center (host center) and a public reference service in a developing country (home center), and use the te... The impact of training on the home center was assessed by comparing surgical performance before and after training. TI was assessed in 2017 in the host center, and before and after training in the hom... The analysis included 366 hysterectomies performed at the host center in 2017, and 663 hysterectomies performed at the home center between 2015 and 2017. TI in the host center was 82.5%, while in the ... High-quality laparoscopic training in a world-renowned specialized center allowed standardizing laparoscopic hysterectomy procedures and helped to significantly improve TI in the recipient's center wi...

Pregnant woman awareness of obstetric danger signs in developing country: systematic review.

Mother's awareness of obstetric danger signs is the degree of a pregnant woman to fully utilize her knowledge of the signs and symptoms of complications of pregnancy, which helps the mother and family... This review employed the Prisma-ScR checklist. The articles searched in four electronic databases (Scopus, CINAHL, Science Direct, Google Scholar). Variables that used to search the articles (pregnant... The results of the article found 20 studies which met inclusion criteria. The determinants were high educational status, more pregnancy experience, more ANC visit, and labour in the health facility.... The level of awareness is low to medium, only some have fair awareness, in which related to determinant. The recommended effective strategy is to improve the ANC program by assess the risk of obstetri...

Challenges in traumatic spinal cord injury care in developing countries - a scoping review.

To evaluate the leading challenges in developing countries' traumatic spinal cord injury (TSCI) care.... We conducted a systematic search in electronic databases of PubMed, SCOPUS, Web of Science, EMBASE, and Cochrane Library on 16 April 2023. Studies that investigated challenges associated with the mana... We identified 82 articles that met the eligibility criteria including 13 studies on injury prevention, 25 on pre-hospital care, 32 on in-hospital care, and 61 on post-hospital care. Challenges related... Studies focusing on injury prevention and pre-hospital care in TSCI management in developing countries warrant further investigation. It is imperative to develop systematic and evidence-based initiati...